Summarized by Masters of Longevity from Longevity Technology.
A summit sought consensus on biomarkers and proof standards for senotherapeutics.

Key Takeaways
- Researchers convened to set shared senotherapeutic biomarker definitions.
- Consensus is needed to detect human senescent cells reliably.
- Standardization has not established that targeting senescence treats disease.



